Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Finke

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Biochemistry|September 8, 1992
Specificity, stability, and potency of monocyclic beta-lactam inhibitors of human leucocyte elastaseW B Knight, B G Green, R M Chabin, et al.
Journal of Medicinal Chemistry|September 1, 1990
Inhibition of human leukocyte elastase. 1. Inhibition by C-7-substituted cephalosporin tert-butyl estersJ B Doherty, B M Ashe, P L Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastaseJ B Doherty, S K Shah, P E Finke, et al.
Journal of Medicinal Chemistry|October 26, 1992
Orally active beta-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinonesS K Shah, C P Dorn, P E Finke, et al.
Journal of Medicinal Chemistry|March 19, 1993
Orally active beta-lactam inhibitors of human leukocyte elastase. 2. Effect of C-4 substitutionW K Hagmann, A L Kissinger, S K Shah, et al.
Nature|July 10, 1986
Cephalosporin antibiotics can be modified to inhibit human leukocyte elastaseJ B Doherty, B M Ashe, L W Argenbright, et al.
Journal of Medicinal Chemistry|June 23, 1995
Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-onesP E Finke, S K Shah, D S Fletcher, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Cyclopentane-based human NK1 antagonists. Part 1: discovery and initial SARPaul E Finke, Laura C Meurer, Dorothy A Levorse, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanesP E Finke, L C Meurer, B Oates, et al.
Gastroenterology|September 22, 2010
Mature chief cells are cryptic progenitors for metaplasia in the stomachKi Taek Nam, Hyuk-Joon Lee, Josane F Sousa, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Biochemistry|September 8, 1992
Specificity, stability, and potency of monocyclic beta-lactam inhibitors of human leucocyte elastaseW B Knight, B G Green, R M Chabin, et al.
Journal of Medicinal Chemistry|September 1, 1990
Inhibition of human leukocyte elastase. 1. Inhibition by C-7-substituted cephalosporin tert-butyl estersJ B Doherty, B M Ashe, P L Barker, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Chemical, biochemical, pharmacokinetic, and biological properties of L-680,833: a potent, orally active monocyclic beta-lactam inhibitor of human polymorphonuclear leukocyte elastaseJ B Doherty, S K Shah, P E Finke, et al.
Journal of Medicinal Chemistry|October 26, 1992
Orally active beta-lactam inhibitors of human leukocyte elastase-1. Activity of 3,3-diethyl-2-azetidinonesS K Shah, C P Dorn, P E Finke, et al.
Journal of Medicinal Chemistry|March 19, 1993
Orally active beta-lactam inhibitors of human leukocyte elastase. 2. Effect of C-4 substitutionW K Hagmann, A L Kissinger, S K Shah, et al.
Nature|July 10, 1986
Cephalosporin antibiotics can be modified to inhibit human leukocyte elastaseJ B Doherty, B M Ashe, L W Argenbright, et al.
Journal of Medicinal Chemistry|June 23, 1995
Orally active beta-lactam inhibitors of human leukocyte elastase. 3. Stereospecific synthesis and structure-activity relationships for 3,3-dialkylazetidin-2-onesP E Finke, S K Shah, D S Fletcher, et al.
Bioorganic & Medicinal Chemistry Letters|July 11, 2006
Cyclopentane-based human NK1 antagonists. Part 1: discovery and initial SARPaul E Finke, Laura C Meurer, Dorothy A Levorse, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2001
Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 3: a proposed pharmacophore model for 1-[N-(methyl)-N-(phenylsulfonyl)amino]-2-(phenyl)-4-[4-(substituted)piperidin-1-yl]butanesP E Finke, L C Meurer, B Oates, et al.
Gastroenterology|September 22, 2010
Mature chief cells are cryptic progenitors for metaplasia in the stomachKi Taek Nam, Hyuk-Joon Lee, Josane F Sousa, et al.
Pageof 7